VANCOUVER, British Columbia, Oct. 31, 2017 /CNW/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF) and (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that on October 26, 2017, the CSPA Group's extraction team from LDS Scientific began extraction and distillation of raw fresh frozen whole plant material for the purpose of conversion into medicinal cannabis products. An independent third party laboratory tested the whole plant material prior to processing. The results showed no trace amounts of pesticides, fungicides, mold or infestation. The LDS Scientific team is using fresh frozen whole plant material in order to preserve the complex array of cannabinoids, terpenes and flavonoids for inclusion into its medical cannabis products. The whole plant methodology may have additional benefits for patients if the entourage effect from combinations of plant chemicals described by some commentators results in enhanced benefits. There is no current clinical data developed in the U.S. to support these hypotheses, and the large majority of commentary is driven by anecdotal patient statements.
Brad Eckenweiler CEO of LDS stated, "The extraction and distillation of whole plant material began last week and medicinal cannabis product formulations and distillate processing is beginning today. We will run sample products and begin taking orders this week and based on those orders we will schedule corresponding production runs. We are confident that the market is ready for our products and that customers will appreciate the added benefit of knowing that each and every product has been tested and is honestly represented in dosage and quality." The LDS Scientific team anticipates releasing sales figures by the end of November 2017.
About Lifestyle Delivery Systems Inc.
The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking, but also a new way to accurately meter the dosage and assure the purity of the product. In addition, with the entering into its management services agreements with NHMC, Inc. and CSPA Group, Inc., the Company has begun its direct involvement in the growing of medicinal ingredients for, and the manufacturing of, its products. From seed to sale, the Company's products and ingredients will be tested for quality and composition throughout the formulation and production processes, resulting in a delivery system that is safe, consistent and effective.
On behalf of the board of directors of Lifestyle Delivery Systems Inc.
Brad Eckenweiler, CEO & Director
FOR MORE INFORMATION, PLEASE CONTACT:
Skanderbeg Capital Advisors
Cautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.
SOURCE Lifestyle Delivery Systems Inc.